Underrecognition of Fecal Incontinence in Systemic Sclerosis: Discrepancies Between the Rome IV Diagnostic Questionnaires and the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal 2.0 Questionnaire | Synapse
February 17, 2026The Journal of Rheumatology0 citations
Underrecognition of Fecal Incontinence in Systemic Sclerosis: Discrepancies Between the Rome IV Diagnostic Questionnaires and the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal 2.0 Questionnaire
To investigate discrepancies in the recognition of fecal incontinence in systemic sclerosis using different diagnostic questionnaires.
Assessment of fecal incontinence through Rome IV Diagnostic Questionnaires and UCLA Scleroderma Clinical Trials Consortium Gastrointestinal 2.0 Questionnaire.
Comparison of reported symptoms between the two questionnaires in patients with systemic sclerosis.
Findings reveal significant underrecognition of fecal incontinence among systemic sclerosis patients.
Quality of life impacts were notably greater for those with gastrointestinal symptoms.
Abstract
Gastrointestinal (GI) involvement in systemic sclerosis (SSc) is common, with up to 87% of people affected. 1 Of all SSc manifestations, GI disease has the greatest impact on quality of life. 2